BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for NOVAVAX, INC. · Biotechnology company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $30,000.00 income · posted Oct 16, 2025

Lobbying activity 1

Health Issues

Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.